{"schema_version":"secwatch.filing_event.v1","accession":"0001447362-25-000096","form_type":"8-K","ticker":"CSTL","cik":"0001447362","company_name":"CASTLE BIOSCIENCES INC","filed_at":"2025-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.011535+00:00","generated_at":"2026-05-17T21:24:34.360402+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Castle Biosciences Q2 revenue $86.2M, raises FY2025 guidance; core test volumes up 33% YoY","bullets":["Q2 revenue $86.2M (vs $87.0M); adjusted revenue $86.2M. Core tests (DecisionDx-Melanoma, TissueCypher) volumes up 33% YoY.","TissueCypher test reports nearly doubled to 9,170 (from 4,782); DecisionDx-Melanoma up 4% to 9,981.","Raising FY2025 total revenue guidance to $310-320M from $287-297M, citing strong core test performance.","Net income $4.5M ($0.16 diluted EPS) vs $8.9M ($0.32) YoY; adjusted EBITDA $10.4M vs $21.5M.","FDA Breakthrough Device designation for DecisionDx-Melanoma; closed Previse acquisition and SciBase collaboration."],"urls":{"canonical":"https://secwatch.observer/filing/0001447362-25-000096","json":"https://secwatch.observer/filing/0001447362-25-000096.json","markdown":"https://secwatch.observer/filing/0001447362-25-000096.md","text":"https://secwatch.observer/filing/0001447362-25-000096.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000096/0001447362-25-000096-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1447362/000144736225000096/cstl-20250804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:24:34.360402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}